av/amphastar-pharmaceuticals--big.svg

COM:AMPHASTAR

Amphastar Pharmaceuticals

  • Stock

USD

Last Close

44.55

22/11 21:00

Market Cap

1.83B

Beta: -

Volume Today

394.77K

Avg: -

Preview

Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page

Subscribe NowHelp
Dec '13
Dec '14
Dec '15
Dec '16
Dec '17
Dec '18
Dec '19
Dec '20
Dec '21
Dec '22
Dec '23
net income
11.86M
-
-10.70M
190.20%
-2.79M
73.95%
10.53M
477.90%
4.51M
57.20%
-6.66M
247.74%
46.51M
798.27%
1.10M
97.64%
63.30M
5,670.37%
91.39M
44.37%
137.54M
50.51%
depreciation and amortization
13.08M
-
14.45M
10.48%
13.25M
8.28%
14.56M
9.90%
15.44M
5.99%
16.52M
7.00%
21.12M
27.88%
25.18M
19.22%
26.75M
6.24%
28.74M
7.43%
41.78M
45.36%
deferred income tax
2.08M
-
-8.24M
496.16%
-7.88M
4.40%
-3.27M
58.50%
3.93M
220.24%
-1.88M
147.75%
7.55M
502.13%
1.12M
85.13%
4.21M
274.80%
-15.75M
474.22%
-12.58M
20.14%
stock based compensation
7.04M
-
9.28M
31.91%
12.81M
38.09%
15.12M
18.02%
17.09M
12.98%
16.68M
2.38%
17.30M
3.69%
20.50M
18.52%
18.69M
8.84%
17.86M
4.43%
20.24M
13.34%
change in working capital
-3.23M
-
15.62M
583.41%
-5.14M
132.90%
297K
105.78%
582K
95.96%
12.10M
1,979.73%
-51.75M
527.52%
9.13M
117.64%
-1.92M
121.08%
-32.18M
1,572.40%
-24.21M
24.76%
accounts receivables
11.82M
-
1.21M
89.77%
-11.01M
1,010.08%
6.38M
157.91%
-8.10M
227.05%
-16.30M
101.12%
6.70M
141.13%
-20.16M
400.81%
-14.92M
25.99%
-10.13M
32.10%
-26.09M
157.46%
inventory
-18.54M
-
6.57M
135.41%
9.78M
48.90%
-9.71M
199.39%
18.65M
291.97%
-5.98M
132.09%
-41.10M
586.88%
15.30M
137.22%
1.26M
91.78%
-11.75M
1,033.70%
-1.72M
85.32%
accounts payables
4.20M
-
5.50M
30.86%
-3.13M
156.93%
-823K
73.71%
6.69M
912.52%
29.16M
336.06%
-17.94M
161.51%
14.96M
183.42%
3.02M
79.84%
-736K
124.40%
13.24M
1,898.51%
other working capital
-720K
-
2.34M
425.56%
-770K
132.85%
4.46M
678.96%
-16.65M
473.55%
5.22M
131.37%
591K
88.69%
-972K
264.47%
8.72M
997.43%
-9.56M
209.63%
-9.64M
0.76%
other non cash items
217K
-
648K
198.62%
420K
35.19%
1.31M
212.86%
-2.34M
277.85%
1.43M
161.15%
1.04M
27.50%
240K
76.83%
-13.03M
5,529.58%
-878K
93.26%
20.73M
2,460.59%
net cash provided by operating activities
31.04M
-
21.05M
32.18%
10.68M
49.26%
38.56M
261.01%
39.21M
1.68%
38.19M
2.60%
41.76M
9.35%
57.27M
37.12%
97.99M
71.12%
89.18M
8.99%
183.50M
105.76%
investments in property plant and equipment
-18.30M
-
-20.50M
12.00%
-16.05M
21.72%
-21.38M
33.25%
-35.10M
64.15%
-46.81M
33.36%
-41.55M
11.22%
-33.85M
18.53%
-27.46M
18.90%
-24.03M
12.46%
-38.17M
58.80%
acquisitions net
-18.35M
-
-12.46M
-
2M
116.05%
4.64M
132.25%
421K
-
-506.41M
120,386.46%
purchases of investments
-3.60M
-
-5.64M
56.72%
-308K
94.54%
-8.81M
2,762.01%
-13.56M
53.79%
-17.38M
28.16%
-35.76M
105.82%
-144.56M
304.23%
sales maturities of investments
513K
-
3.08M
-
3.65M
18.70%
91K
97.51%
12.41M
-
18.77M
51.24%
27.97M
49.00%
38.62M
38.09%
other investing activites
-509K
-
-922K
81.14%
-878K
4.77%
-5.13M
484.40%
-3.66M
28.65%
198K
105.41%
-157K
179.29%
-1.41M
800.64%
-2.61M
84.72%
-1.37M
47.47%
1.39M
201.31%
net cash used for investing activites
-18.30M
-
-39.77M
117.36%
-16.93M
57.45%
-39.50M
133.39%
-38.76M
1.89%
-42.18M
8.84%
-50.53M
19.78%
-36.41M
27.93%
-28.67M
21.26%
-32.78M
14.32%
-649.12M
1,880.40%
debt repayment
-73.15M
-
-54.21M
25.89%
-8.99M
83.42%
-14.65M
62.96%
-9.71M
33.72%
-5.71M
41.26%
-6.78M
18.86%
-8.40M
23.89%
-37.90M
351.15%
-1.78M
95.30%
-501.26M
28,045.03%
common stock issued
38.02M
-
1.32M
96.53%
20.64M
1,463.56%
13.76M
33.34%
38.04M
176.46%
18.30M
51.89%
23.16M
26.60%
15.93M
31.25%
15.66M
1.68%
10.97M
29.91%
common stock repurchased
-199K
-
-734K
268.84%
-10.49M
1,328.61%
-9.91M
5.51%
-30.75M
210.32%
-25.05M
18.54%
-22.29M
11.00%
-24.43M
9.57%
-28.87M
18.21%
-39.91M
38.22%
-58.14M
45.69%
dividends paid
-52.08M
-
-20.29M
61.04%
-10.20M
49.73%
-20.31M
-
-23.16M
-
-15.93M
31.25%
-15.66M
1.68%
-454.09M
2,800.07%
other financing activites
63.98M
-
101.12M
58.05%
40.68M
59.77%
21.26M
47.74%
18.98M
10.71%
38.04M
100.37%
6.99M
81.62%
30.58M
337.42%
29.76M
2.69%
15.25M
48.75%
1.46B
9,450.97%
net cash used provided by financing activities
-9.37M
-
32.12M
442.76%
2.24M
93.03%
7.14M
219.18%
-7.72M
208.10%
25.01M
424.02%
-3.78M
115.13%
-2.25M
40.63%
-37.02M
1,548.17%
-26.44M
28.58%
454.09M
1,817.51%
effect of forex changes on cash
845K
-
2.25M
166.63%
81K
96.40%
504K
522.22%
-274K
154.37%
-104K
62.04%
352K
438.46%
-223K
163.35%
-220K
1.35%
-282K
28.18%
net change in cash
3.37M
-
14.24M
322.08%
-1.75M
112.32%
6.28M
458.04%
-6.76M
207.64%
20.74M
406.85%
-12.65M
160.99%
18.96M
249.83%
32.08M
69.23%
29.75M
7.28%
-11.80M
139.68%
cash at beginning of period
50.21M
-
53.59M
6.72%
67.83M
26.58%
66.07M
2.59%
72.35M
9.50%
67.46M
6.77%
88.20M
30.75%
75.55M
14.34%
94.51M
25.09%
126.59M
33.95%
156.33M
23.50%
cash at end of period
53.59M
-
67.83M
26.58%
66.07M
2.59%
72.35M
9.50%
65.59M
9.34%
88.20M
34.47%
75.55M
14.34%
94.51M
25.09%
126.59M
33.95%
156.33M
23.50%
144.53M
7.55%
operating cash flow
31.04M
-
21.05M
32.18%
10.68M
49.26%
38.56M
261.01%
39.21M
1.68%
38.19M
2.60%
41.76M
9.35%
57.27M
37.12%
97.99M
71.12%
89.18M
8.99%
183.50M
105.76%
capital expenditure
-18.30M
-
-20.50M
12.00%
-16.05M
21.72%
-21.38M
33.25%
-35.10M
64.15%
-46.81M
33.36%
-41.55M
11.22%
-33.85M
18.53%
-27.46M
18.90%
-24.03M
12.46%
-38.17M
58.80%
free cash flow
12.74M
-
553K
95.66%
-5.37M
1,070.34%
17.18M
420.13%
4.11M
76.07%
-8.62M
309.66%
207K
102.40%
23.41M
11,209.66%
70.54M
201.30%
65.15M
7.64%
145.34M
123.09%

All numbers in USD (except ratios and percentages)